vs

Side-by-side financial comparison of Broadway Financial Corp (BYFC) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

Broadway Financial Corp is the larger business by last-quarter revenue ($9.4M vs $5.0M, roughly 1.9× cbdMD, Inc.). Broadway Financial Corp runs the higher net margin — 1934.0% vs -5.6%, a 1939.6% gap on every dollar of revenue. On growth, Broadway Financial Corp posted the faster year-over-year revenue change (10.1% vs -1.9%). Broadway Financial Corp produced more free cash flow last quarter ($-13.0K vs $-977.3K). Over the past eight quarters, Broadway Financial Corp's revenue compounded faster (9.7% CAGR vs 7.1%).

Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

BYFC vs YCBD — Head-to-Head

Bigger by revenue
BYFC
BYFC
1.9× larger
BYFC
$9.4M
$5.0M
YCBD
Growing faster (revenue YoY)
BYFC
BYFC
+12.0% gap
BYFC
10.1%
-1.9%
YCBD
Higher net margin
BYFC
BYFC
1939.6% more per $
BYFC
1934.0%
-5.6%
YCBD
More free cash flow
BYFC
BYFC
$964.3K more FCF
BYFC
$-13.0K
$-977.3K
YCBD
Faster 2-yr revenue CAGR
BYFC
BYFC
Annualised
BYFC
9.7%
7.1%
YCBD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BYFC
BYFC
YCBD
YCBD
Revenue
$9.4M
$5.0M
Net Profit
$1.0M
$-283.1K
Gross Margin
59.8%
Operating Margin
-5.7%
Net Margin
1934.0%
-5.6%
Revenue YoY
10.1%
-1.9%
Net Profit YoY
-21.8%
-1975.7%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BYFC
BYFC
YCBD
YCBD
Q4 25
$9.4M
$5.0M
Q3 25
$9.0M
$4.7M
Q2 25
$8.1M
$4.6M
Q1 25
$8.3M
$4.7M
Q4 24
$8.6M
$5.1M
Q3 24
$8.7M
$4.6M
Q2 24
$8.2M
$5.2M
Q1 24
$7.8M
$4.4M
Net Profit
BYFC
BYFC
YCBD
YCBD
Q4 25
$1.0M
$-283.1K
Q3 25
$-23.9M
$-680.0K
Q2 25
$752.0K
$-895.3K
Q1 25
$-2.7M
$-480.8K
Q4 24
$1.3M
$15.1K
Q3 24
$516.0K
$-152.8K
Q2 24
$256.0K
$459.7K
Q1 24
$-154.0K
$-3.0M
Gross Margin
BYFC
BYFC
YCBD
YCBD
Q4 25
59.8%
Q3 25
58.8%
Q2 25
61.5%
Q1 25
62.3%
Q4 24
66.5%
Q3 24
53.9%
Q2 24
65.8%
Q1 24
59.0%
Operating Margin
BYFC
BYFC
YCBD
YCBD
Q4 25
-5.7%
Q3 25
-256.2%
-14.5%
Q2 25
12.8%
-19.6%
Q1 25
-45.3%
-10.2%
Q4 24
21.7%
-1.7%
Q3 24
8.5%
-6.9%
Q2 24
4.8%
-7.4%
Q1 24
-2.9%
-35.4%
Net Margin
BYFC
BYFC
YCBD
YCBD
Q4 25
1934.0%
-5.6%
Q3 25
-264.2%
-14.4%
Q2 25
9.3%
-19.4%
Q1 25
-32.3%
-10.1%
Q4 24
15.3%
0.3%
Q3 24
5.9%
-3.4%
Q2 24
3.1%
8.9%
Q1 24
-2.0%
-68.8%
EPS (diluted)
BYFC
BYFC
YCBD
YCBD
Q4 25
$0.02
Q3 25
$-2.86
Q2 25
$0.00
Q1 25
$-0.39
Q4 24
$0.07
Q3 24
$-0.03
Q2 24
$0.02
$-0.15
Q1 24
$-0.02
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BYFC
BYFC
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$10.5M
$3.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$262.8M
$9.0M
Total Assets
$1.3B
$11.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BYFC
BYFC
YCBD
YCBD
Q4 25
$10.5M
$3.4M
Q3 25
$19.7M
$2.3M
Q2 25
$29.5M
$1.1M
Q1 25
$15.8M
$1.8M
Q4 24
$61.4M
$2.0M
Q3 24
$97.1M
$2.5M
Q2 24
$89.8M
$2.4M
Q1 24
$67.1M
$2.1M
Stockholders' Equity
BYFC
BYFC
YCBD
YCBD
Q4 25
$262.8M
$9.0M
Q3 25
$261.7M
$7.2M
Q2 25
$284.7M
$6.1M
Q1 25
$283.6M
$665.8K
Q4 24
$285.0M
$1.8M
Q3 24
$286.2M
$2.0M
Q2 24
$282.1M
$3.0M
Q1 24
$281.1M
$3.1M
Total Assets
BYFC
BYFC
YCBD
YCBD
Q4 25
$1.3B
$11.8M
Q3 25
$1.3B
$10.4M
Q2 25
$1.2B
$9.9M
Q1 25
$1.3B
$10.9M
Q4 24
$1.3B
$11.5M
Q3 24
$1.4B
$10.6M
Q2 24
$1.4B
$13.8M
Q1 24
$1.4B
$14.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BYFC
BYFC
YCBD
YCBD
Operating Cash FlowLast quarter
$230.0K
$-812.5K
Free Cash FlowOCF − Capex
$-13.0K
$-977.3K
FCF MarginFCF / Revenue
-0.1%
-19.5%
Capex IntensityCapex / Revenue
2.6%
3.3%
Cash ConversionOCF / Net Profit
0.22×
TTM Free Cash FlowTrailing 4 quarters
$2.3M
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BYFC
BYFC
YCBD
YCBD
Q4 25
$230.0K
$-812.5K
Q3 25
$3.8M
$-240.7K
Q2 25
$3.0M
$-704.2K
Q1 25
$-4.3M
$-189.5K
Q4 24
$1.4M
$-317.9K
Q3 24
$6.1M
$167.4K
Q2 24
$9.8M
$289.8K
Q1 24
$-11.7M
$-704.1K
Free Cash Flow
BYFC
BYFC
YCBD
YCBD
Q4 25
$-13.0K
$-977.3K
Q3 25
$3.7M
$-243.6K
Q2 25
$3.0M
$-705.7K
Q1 25
$-4.4M
$-205.0K
Q4 24
$1.3M
$-482.3K
Q3 24
$6.1M
$157.4K
Q2 24
$9.7M
Q1 24
$-11.7M
$-708.7K
FCF Margin
BYFC
BYFC
YCBD
YCBD
Q4 25
-0.1%
-19.5%
Q3 25
41.1%
-5.2%
Q2 25
37.0%
-15.3%
Q1 25
-52.4%
-4.3%
Q4 24
14.7%
-9.4%
Q3 24
69.6%
3.5%
Q2 24
118.9%
Q1 24
-149.7%
-16.2%
Capex Intensity
BYFC
BYFC
YCBD
YCBD
Q4 25
2.6%
3.3%
Q3 25
1.2%
0.1%
Q2 25
0.2%
0.0%
Q1 25
0.2%
0.3%
Q4 24
1.6%
3.2%
Q3 24
0.3%
0.2%
Q2 24
0.5%
0.0%
Q1 24
0.7%
0.1%
Cash Conversion
BYFC
BYFC
YCBD
YCBD
Q4 25
0.22×
Q3 25
Q2 25
4.00×
Q1 25
Q4 24
1.06×
-21.06×
Q3 24
11.85×
Q2 24
38.21×
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BYFC
BYFC

Segment breakdown not available.

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons